Akums Drugs and Pharmaceuticals Ltd Signs Exclusive Master Sales Agreement with Caregen Co., Ltd

Akums Drugs and Pharmaceuticals Limited (Akums) has entered into an exclusive Master Sales Agreement with Caregen Co., Ltd (Caregen), a leading South Korean company in the Nutraceuticals segment. Akums has been granted the exclusive rights to sell certain Caregen products range in India during the term of the agreement. The company will also undertake the packaging, marketing, and selling of Caregen’s line of bulk product under Caregen’s trademark or Akums’s trademark or of Akums’s Clients trademark. Caregen is a global leader in peptide research and development and a global biotechnology company based in South Korea that has commercialized the unlimited expandability of its patented peptides as many innovative products.